Glutamate Antagonist Therapy Reduces Neurologic Deficits Produced by Focal Central Nervous System Ischemia

Archives of Neurology

Volumn 45, Issue 2, 1988, Pages 148-153

  Kochhar, Abha ^a   Zivin, Justin A ^a,b   Lyden, Patrick D ^a,b   Mazzarella, Vincent ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN EMBOLISM; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SPINAL CORD ISCHEMIA;

ANIMAL; BEHAVIOR, ANIMAL; DIBENZOCYCLOHEPTENES; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; GLUTAMATES; INTRACRANIAL EMBOLISM AND THROMBOSIS; ISCHEMIA; ISCHEMIC ATTACK, TRANSIENT; MALE; RABBITS; SPINAL CORD;

EID: 0023836750     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1988.00520260034016     Document Type: Article

References (55)

1. Greenamyre JT: The role of glutamate in neurotransmission and in neurologic disease. Arch Neurol 1986;43:1058-1063.
2. Rothman SM, Olney JW: Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986;19:105-111.
3. Wieloch T: Endogenous excitotoxins as possible mediators of ischemic and hypoglycemic brain damage. Epilepsia 1985;26:501.
4. Meldrum BS: Excitatory amino acids and anoxic/ischemic brain damage. Trends Neurosci 1985;8:47-48.
5. Jørgensen MB, Diemer NH: Selective neuron loss after cerebral ischemia in the rat: Possible role of transmitter glutamate. Acta Neurol Scand 1982;66:536-546.
6. Watkins JC, Evans R: Excitatory amino acid transmitters. Annu Rev Pharmacol Toxicol 1981;21:165-204.
7. Fagg GE, Foster AC: Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscience 1983;9:701-719.
8. Fonnum F: Glutamate: A neurotransmitter in the mammalian brain. J Neurochem 1984;42:1-11.
9. McLennan H: Receptors for the excitatory amino acids in the mammalian central nervous system. Prog Neurobiol 1983;20:251-271.
10. Davies J, Evans RH, Jones AW, et al: Differential activation and blockade of excitatory amino acid receptors in the mammalian and amphibian central nervous systems. Comp Biochem Physiol 1982;72C:211-224.
11. Fagg GE, Foster AC, Mena EE: Chloride and calcium ions reveal a pharmacologically distinct population of L-glutamate binding sites in synaptic membranes: Correspondence between biochemical and electrophysiological data. J Neurosci 1982;2:958-965.
12. Monaghan DT, Holets VR, Toy DR, et al: Anatomical distributions of four pharmacologically distinct 3H-L-glutamate binding sites. Nature 1983;306:176-179.
13. Greenamyre JT, Olson JM, Penney JB, et al: Autoradiographic characterization of N-methyl-D-aspartate-quisaualate- and kainatesensitive glutamate binding sites. J Pharmacol Exp Ther 1985;233:254-263.
14. Olney JW: Neurotoxicity of excitatory amino acids, in McGeer EG, Olney JW, McGeer PL (eds): Kainic Acid as a Tool in Neurobiology. New York, Raven Press, 1978, pp 95-121.
15. Olney JW, Ho OL, Rhee V: Cytotoxic effects of acidic and sulphur containing amino acids on infant mouse central nervous system. Exp Brain Res 1971;14:61-76.
16. Mangano RM, Schwarcz R: Chronic infusion of endogenous excitatory amino acids into the rat striatum and hippocampus. Brain Res Bull 1983;10:47-51.
17. McBean GJ, Roberts PJ: Chronic infusion of L-glutamate causes neurotoxicity in rat striatum. Brain Res 1984;290:372-375.
18. Kohler C, Schwarcz R: Monosodium glutamate: Increased neurotoxicity after removal of neuronal re-uptake sites. Brain Res 1981;211:485-491.
19. Olney JW: Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science 1969;164:719-721.
20. Foster AC, Fagg GE: Acidic amino acid binding sites in mammalian neuronal membranes: Their characteristics and relationship to synaptic receptors. Brain Res Rev 1984;7:103-164.
21. Meldrum BS: Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin Sci 1985;68:113-122.
22. Schwarcz R, Meldrum B: Excitatory amino acid antagonists provide a therapeutic approach to neurological disorders. Lancet 1985;2:140-143.
23. Croucher MJ, Collins JF, Meldrum BS: Anticonvulsant action of excitatory amino acids antagonists. Science 1982;216:899-901.
24. Meldrum BS: Amino acid neurotransmitters and new approaches to anticonvulsant drug action. Epilepsia 1984;25:S140-S149.
25. Simon RP, Swan JH, Griffiths T, et al: Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 1984;226:850-852.
26. Meldrum BS, Griffiths T, Evans M: Hypoxia and neuronal hyperexcitability: A clue to mechanisms of brain protection, in Wauquier A, Borgers M, Amery WK (eds): Protection of Tissue Against Hypoxia. Amsterdam, Elsevier Science Publishers, 1982, pp 275-286.
27. Wieloch T: Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science 1985;230:681-683.
28. Chapman AG, Collins JF, Meldrum BS: Uptake of a novel anticonvulsant compound, 2-amino-7-phosphono-(4,5,3H)-heptanoic acid, into mouse brain. Neurosci Lett 1983;37:75-80.
29. Clineschmidt BV, Martin GE, Bunting PR: Anticonvulsant activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Dev Res 1982;2:123-134.
30. Wong EHF, Kemp JA, Priestley T, et al: The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 1986;83:7104-7108.
31. Zivin JA, DeGirolami U, Kochhar A, et al: A model for quantitative evaluation of embolic stroke therapy. Brain Res, in press.
32. Zivin JA, DeGirolami U: Spinal cord infarction: A highly reproducible stroke model. Stroke 1980;11:200-202.
33. Zivin JA, DeGirolami U, Hurwitz EL: Spectrum of neurological deficits in experimental CNS ischemia. Arch Neurol 1982;39:408-412.
34. Waud DR: On biological assays involving quantal responses. J Pharmacol Exp Ther 1972;183:577-607.
35. Zivin JA, Fisher M, DeGirolami U, et al: Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 1985;230:1289-1292.
36. Winer BJ: Statistical Principles in Experimental Design, ed 2. New York, McGraw-Hill International Book Co, 1971.
37. DeGirolami U, Zivin JA: Neuropathology of experimental spinal cord ischemia in the rabbit. J Neuropathol Exp Neurol 1982;41:129-149.
38. McDonald DA, Potter JM: The distribution of blood to the brain. J Physiol 1951;144:356-371.
39. Scremin OU, Sonnenschein RR, Rubinstein EM: Cerebrovascular anatomy and blood flow measurements in the rabbit. J Cereb Blood Flow Metab 1982;2:44-66.
40. Molinari GF, Laurent JP: A classification of experimental models of brain ischemia. Stroke 1976;7:14-17.
41. Benveniste H, Drejer J, Schousboe A, et al: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984;43:1369-1374.
42. Simon RP, Griffiths T, Evans MC, et al: Calcium overload in selectively vulnerable neurons of the hippocampus during and after ischemia: An EM study in the rat. J Cereb Blood Flow Metab 1984;4:350-361.
43. Hagberg H, Lehmann A, Sandberg M, et al: Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments. J Cereb Blood Flow Metab 1985;5:413-419.
44. Drejer J, Benveniste H, Diemer NJ, et al: Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. J Neurochem 1985;45:145-151.
45. Silverstein FS, Buchanon K, Johnston MV: Hypoxia-ischemia causes severe but reversible depression of striatal synaptosomal 3H-glutamate update, abstracted. Ann Neurol 1985;18:122.
46. Rothman SM: The neurotoxicity of excitatory amino acids is produced by passive chloride influx. J Neurosci 1985;5:1483-1489.
47. Hauptman M, Nelson D, Wilson DF, et al: Neurotransmitter amino acids in the CNS: II. Some changes in amino acid levels in rat brain synaptosomes during and after in vitro anoxia and simulated ischemia. Brain Res 1984;304:23-35.
48. Berdichevsky E, Riveros N, Sanchez-Armass S, et al: Kainate, N-methyl aspartate, and other excitatory amino acids increase calcium influx into rat brain cortex cells in vitro. Neurosci Lett 1983;36:75-80.
49. Dingledine R: N-methyl aspartate activates voltage dependent calcium conductance in rat hippocampal pyramidal cells. J Physiol 1983;343:385-405.
50. Donaldson PL, Duce IR, Usherwood PN: Calcium accumulation precedes the degenerative effects of L-glutamate on locust muscle fibers. Brain Res 1983;274:261-265.
51. Jancso G, Karcsu S, Kiraly E, et al: Neurotoxin induced nerve cell degeneration: Possible involvement of calcium. Brain Res 1984;295:211-216.
52. Choi DW: Glutamate neurotoxicity in cortical cell culture is calcium-dependent. Neurosci Lett 1985;58:293-297.
53. Farber JL, Chien KR, Mittnacht S: The pathogenesis of irreversible cell injury in ischemia. Am J Pathol 1981;102:271-281.
54. Raichle ME: The pathophysiology of brain ischemia. Ann Neurol 1983;13:2-10.
55. Dienel GA: Regional accumulation of calcium in the postischemic rat brain. J Neurochem 1984;43:913-925.